Home→ Research Archive→ Health Topics→Neurological Health

Health Topics — Neurological Health

Neurological Health

The Neurological Health pillar examines cannabinoid research in some of the most serious conditions in medicine — Huntington's disease, Parkinson's disease, multiple sclerosis, and glaucoma. The evidence is predominantly preclinical throughout, with MS representing the most developed human trial record. The articles are careful about the distance between animal model findings and human disease.

Botanical illustration — representing the neurological health research pillar

Neurological Health — Cannabinoid Research Pillar

Cannabinoids and Multiple Sclerosis: The Current Research Picture

MS has more human cannabinoid trial data than almost any other neurological condition — but most of it involves THC, not CBD or CBG, and that distinction changes everything about how to read the evidence.

Research Article · Neurological

CBG and Huntington's Disease: What Animal Models Have Shown

Animal model research has found that CBG produces neuroprotective effects in a mouse model of Huntington's disease — what the study found, what a mouse model can and cannot establish, and the considerable distance from those results to human disease.

Research Article · Neurological

CBG and Neuroprotection: A Research Overview

CBG has documented neuroprotective activity in preclinical models — what neuroprotection actually means as a research concept, what the evidence shows, and an honest account of how far that evidence extends.

Research Article · Neurological

CBG and Parkinson's Disease Research: Early Preclinical Findings

Preclinical research has examined CBG derivatives in animal models of Parkinson's disease — what was found, what the mechanisms are, and why the distance between a rodent model and human Parkinson's matters enormously here.

Research Article · Neurological

Glaucoma and Cannabinoids: Intraocular Pressure and Optic Nerve Research

One of the oldest lines of cannabinoid research — what four decades of intraocular pressure studies have found, why the findings haven't translated to clinical use, and what a newer neuroprotective angle adds to the picture.

Research Article · Neurological

Eye Pressure, Glaucoma, and Four Decades of Cannabinoid Research

One of the oldest observations in cannabinoid science — a plain account of what the research has found, and why it has not translated into treatment.

Experience Article · Neurological

Migraines and the Endocannabinoid System: What the Research Has Examined

A specific CSF anandamide finding in chronic migraineurs, the clinical endocannabinoid deficiency hypothesis, and a 2024 placebo-controlled trial — what each establishes and where the honest limits are for hemp-derived preparations.

Experience Article · Neurological

When You Get Migraines — What the Research Shows

For the person with frequent migraines who has heard that cannabinoids might help and wants an honest account of what the science has actually found — including one specific finding about migraineurs specifically.

Experience Article · Neurological

Multiple Sclerosis and Cannabinoids — A Plain Account of What the Research Has Found

MS has generated more human cannabinoid trial data than any other neurological condition — here is what that research actually shows, and where the important distinctions lie.

Experience Article · Neurological

When Someone You Love Has a Neurological Diagnosis

What the cannabinoid research has examined — and what it hasn't — for patients and caregivers who deserve honest answers.

Experience Article · Neurological

CBG, Brain Injury, and Neuroinflammation: What the Preclinical Research Shows

The secondary injury cascade after traumatic brain injury involves neuroinflammation and oxidative stress — and CBG has been studied in several preclinical models of both.

Research Article · Neurological